Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: A prospective study

References

• Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. Cancer J Clin 2001;51:15–36
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30
   PubMed Web of Science ®Google Scholar
• Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26:879–85
   PubMed Web of Science ®Google Scholar
• Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP. Pathological tumour-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3553–62
   PubMed Web of Science ®Google Scholar
• Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714–20
   PubMed Web of Science ®Google Scholar
• Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, et al. Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 2011;96:2750–5
   PubMed Web of Science ®Google Scholar
• Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol 2013;24:672–9
   PubMed Web of Science ®Google Scholar
• Swan RZ, Sindram D, Martinie JB, Iannitti DA. Operative microwave ablation for hepatocellular carcinoma: Complications, recurrence, and long-term outcomes. J Gastrointest Surg 2013;17:719–29
   PubMed Web of Science ®Google Scholar
• Li X, Fan WJ, Zhang L, Zhang XP, Jiang H, Zhang JL, et al. CT-guided percutaneous microwave ablation of liver metastases from nasopharyngeal carcinoma. J Vasc Interv Radiol 2013;24:680–4
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Zhang D, Yu X, Gao Y, Ni X. Ultrasound guided percutaneous microwave ablation for small renal cancer: Initial experience. J Urol 2008;180:844–8; discussion 848
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Ierardi AM, Fontana F, Petrillo M, Floridi C, Lucchina N, et al. Microwave ablation of pancreatic head cancer: Safety and efficacy. J Vasc Interv Radiol 2013;24:1513–20
   PubMed Web of Science ®Google Scholar
• Belfiore G, Ronza F, Belfiore MP, Serao N, di Ronza G, Grassi R, et al. Patients’ survival in lung malignancies treated by microwave ablation: Our experience on 56 patients. Eur J Radiol 2013;82:177–81
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Wang B, Xu Q, Yu S, Yonglin Z, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol 2013;82:e11–16
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Yu S, Wang B. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: Initial experience. Int J Hyperthermia 2014;30:150–7
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001;130:971–7
   PubMed Web of Science ®Google Scholar
• Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol 2011;197:W331–6
   PubMed Web of Science ®Google Scholar
• Lim CY, Yun JS, Lee J, Nam KH, Chung WY, Park CS. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 2007;17:347–50
   PubMed Web of Science ®Google Scholar
• Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol 2002;178:699–704
   PubMed Web of Science ®Google Scholar
• Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 2008;18:835–42
   PubMed Web of Science ®Google Scholar
• Bennedbak FN, Hegedus L. Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: A randomized trial comparing one injection with three injections. Thyroid 1999;9:225–33
   PubMedGoogle Scholar
• Qian GJ, Wang N, Shen Q, Sheng YH, Zhao JQ, Kuang M, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: Experimental and clinical studies. Eur Radiol 2012;22:1983–90
   PubMed Web of Science ®Google Scholar
• Dodd GD III, Dodd NA, Lanctot AC, Glueck DA. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology 2013;267:129–36
   PubMed Web of Science ®Google Scholar
• Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 2006;244:296–304
   PubMed Web of Science ®Google Scholar